fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

AmerisourceBergen Corp Agrees To Purchase Walgreens Boots Alliance Inc.’s Pharmaceutical Business

By John F. Heerdink, Jr.

Reportedly, AmerisourceBergen Corp. (ABC) will purchase Walgreens Boots Alliance Inc.’s (WBA) pharmaceutical wholesale businesses for about $6.5 billion in cash and stock, extending its reach in Europe. The deal includes $6.275 billion in cash and 2 million in shares. Walgreens and AmerisourceBergen also extended existing distribution agreements in the U.S. and the U.K. by several years, deepening their already close ties. Walgreens is AmerisourceBergen’s biggest shareholder with a 30% stake.

The deal is thought to enable AmerisourceBergen to strengthen its global reach, while Walgreens will focus on its main pharmacy business. The acquisition excludes Walgreens operations in China, Italy, and Germany and is expected to close by the end of AmerisourceBergen’s fiscal year.

AmerisourceBergen was advised by JPMorgan Chase & Co. on the deal, and Cravath, Swaine & Moore LLP, Hogan Lovells International LLP, and Morgan, Lewis & Bockius LLP were its legal advisers. Centerview Partners served as Walgreens’ financial adviser, while Cleary Gottlieb Steen & Hamilton LLP and Baker McKenzie LLP as its legal adviser.

Walgreen Boots Alliance (WBA) is a pharmacy-led, health and well-being enterprise with a long history of trusted healthcare services, community pharmacy care, and pharmaceutical wholesaling dates. To learn more about Walgreen Boots Alliance (WBA) and to continue to track its progress please visit the Vista Partners Walgreens Boots Alliance Page.

Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.


(Read Original Story: AmerisourceBergen to Buy Walgreens Unit for $6.5 Billion in Bloomberg)


YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us